Skip to content

LBRX LBRX Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Alkermes logo
AlkermesALKS
$71.32M-3.8%
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
$5.59M
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$1.15M-34.3%
Opko Health logo
Opko HealthOPK
$46.72M-3.1%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$50.79M-9.3%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$11.48M+678%

Other financials

Income statement

See full
Net income-$19.1M-259%
EPS (diluted)-$0.67+95.5%

Balance sheet

See full
Cash & equivalents$320.7M
Total debt$3.5M
Total equity$378.7M+481%
Total assets$393.5M

Cash flow

See full
Operating cash flow-$23.3M-187%
CapEx$32.0K+52.4%
Free cash flow-$23.3M-186%

Valuation

See full
Market cap$888.98M+163%
Enterprise value$571.77M

Returns & leverage

See full
Return on equity-27.9%
Debt / equity
Current ratio35.7×

Where this comes from

Reported directly by LBRX in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LBRX's operating lease liabilities (total)?
LBRX (LBRX) reported operating lease liabilities (total) of $3.47M in Q1 2026.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.